Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia
- 11 January 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 816 (2) , 299-308
- https://doi.org/10.1016/s0006-8993(98)01051-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Kainate Reveals Its TargetsNeuron, 1997
- Neuroprotective Effect of YM9OK, an AMPA-Receptor Antagonist,against Delayed Neuronal Death Induced by Transient Global Cerebral Ischemia in Gerbils and Rats.The Japanese Journal of Pharmacology, 1997
- Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) and its racemate (LY215490)Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Long‐term hippocampal slices: A model system for investigating synaptic mechanisms and pathologic processesJournal of Neuroscience Research, 1995
- Mechanisms of Secondary Brain Damage in Global and Focal Ischemia: A Speculative SynthesisJournal of Neurotrauma, 1995
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- Cloned Glutamate ReceptorsAnnual Review of Neuroscience, 1994
- Ca2+-Independent Release of Glutamate During In Vitro Anoxia in Isolated Nerve TerminalsJournal of Neurochemistry, 1991
- Effect of Ischemia on the In Vivo Release of Striatal Dopamine, Glutamate, and γ‐Aminobutyric Acid Studied by Intracerebral MicrodialysisJournal of Neurochemistry, 1988
- The rat hippocampal slice preparation as an in vitro model of ischemia.Stroke, 1988